Xtandi (Enzalutamide)

 Xtandi (enzalutamide) is an androgen receptor inhibitor used for the treatment of patients with:

• castration-resistant prostate cancer.
• metastatic castration-sensitive prostate cancer.
• non-metastatic castration-sensitive prostate cancer with
• biochemical recurrence at high risk for metastasis

Recommended Dosage:
The recommended dosage of Enzalutamide Capsules/Tablets is 160 mg administered orally once daily with or without food until there is evidence of disease progression or unacceptable toxicity. Patients should take each capsule or tablet whole with an adequate amount of water to ensure that all the therapeutic drug is successfully swallowed. Do not open, chew, or dissolve the capsules. Do not crush, cut, or chew the tablets.

Patients with CRPC or mCSPC receiving treatment with this medicine should also receive a gonadotropic-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy.

• Treatment with Enzalutamide may increase the risk of seizures. Patients with a known history of seizures or other neurological complications must be monitored closely. Do not drive or operate heavy machinery if you experience sudden jerks, dizziness, or loss of consciousness while on treatment.
• Posterior Reversible Encephalopathy Syndrome (PRES) is a rare brain condition associated with enzalutamide. Symptoms include confusion, headache, vision problems, and seizures. If such signs appear, get quick medical attention. Brain imaging may be needed to confirm the diagnosis and stop treatment in case PRES is suspected.
• Allergic reactions to enzalutamide may occur in some patients. These may include rash, swelling, or breathing difficulties. If any signs of hypersensitivity occur, discontinue use and consult a doctor right away. Always inform your healthcare provider (HCP) about past drug allergies before starting therapy.
• This therapeutic drug may increase the risk of heart-related complications such as chest pain, heart attack, or high blood pressure. Patients with ongoing heart complications should be monitored regularly. Report symptoms like chest pain, shortness of breath, or dizziness promptly to your doctor.
• Bone fractures and falls may occur in patients taking this medicine. This may be because of dizziness, muscle weakness, or decreased bone density. Exercise caution during physical activities. Bone health monitoring and fall-prevention strategies are required during treatment.
• Trouble in swallowing (dysphagia) or choking may occur in rare cases. In case patients experience pain while swallowing, coughing, or food sticking in the throat, they should notify a healthcare provider (HCP). Intake plenty of fluids and take the oral capsule whole, not crushed or chewed.
• Enzalutamide Tablet/Capsule is not for use in women. If used by a female partner of a male patient, an appropriate contraception method must be used. This medicine may cause harm to the unborn baby. Men with female partners of childbearing age must use effective birth control during and after treatment.
• Enzalutamide treatment is not for use in breastfeeding women. In case a female comes in contact with the medicine or is accidentally exposed, breastfeeding should be stopped. The medicine may pass into human breast milk and cause harm to the nursing baby.

What documents are required to import XTANDI to India?

XTANDI (enzalutamide) Capsules/Tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is XTANDI available in India?

XTANDI (enzalutamide capsules/tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Xtandi in India (Mumbai, Kolkata,
• Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Xtandi Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

XTANDI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of XTANDI (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Xtandi 40 mg, 80 mg (enzalutamide) price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source XTANDI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Xtandi®?

Enzalutamide is the Generic Name for the trade name drug Xtandi®.

What is the Manufacturer's Name of Xtandi®?

Xtandi® is manufactured by Astellas Pharma US, Inc.

Is Xtandi approved by the FDA?

Yes. Xtandi is approved by the US FDA. Date of first approval: August 31, 2012.

What is the dosage and form of Xtandi® supplied?

Xtandi is supplied in Capsules: 40 mg and Tablets: 40 mg, 80 mg for oral administration.

What are the most common side effects of Xtandi® 40 mg/80 mg?

The most common side effects of Xtandi® are fatigue, musculoskeletal pain, constipation, decreased appetite, falls, hot flush, diarrhea, hemorrhage, fracture, hypertension, and headache.

How much does Xtandi® 40 mg/80 mg cost in India?

Costs of Xtandi Capsules/Tablets may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Xtandi 40 mg/80 mg cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Xtandi® 40 mg/80 mg be available in SAARC countries?

Apart from Gulf countries, Xtandi® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Xtandi® Capsule/Tablet in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Xtandi® 40 mg/80 mg online in India?

Yes, one can buy Xtandi 40 mg/80 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Xtandi® Capsule/Tablets through legal channels.

What are the storage conditions of Xtandi® 40 mg/80 mg?

Store the capsules and tablets of Xtandi at 20 to 25°C (68 to 77°F) in a dry place and keep the container tightly closed. Excursions permitted from 15 to 30°C (59 to 86°F).